The health of our immune system is increasingly linked with the health of our intestinal bacteria. A mouse study from Harvard Medical School now hammers this home for autoimmune disorders, in which the body attacks its own cells. It looked specifically at type 1 diabetes, in which the body destroys the cells that make insulin.
Scientists have long known that the human leukocyte antigen (HLA) complex of proteins (also known as the major histocompatibility complex, or MHC) keep autoimmune responses in check. Certain common variants of the HLA/MHC genes are known to protect against a type 1 diabetes. But until now, how these genes prevent autoimmune reactions has been a mystery.
Don’t mess with my microbiome
The research team, led by Diane Mathis, BSc, PhD and Christophe Benoist, MD, PhD of HMS’s Department of Microbiology and Immunobiology, worked with mice genetically prone to diabetes. They had two key findings.
First, the gene protecting against autoimmunity exerts its effects by altering the gut microbiota. Second, this protection could be undercut three ways: by giving the mice antibiotics during the first six weeks of life, by giving their mothers antibiotics late in gestation or simply by raising the mice in a sterile, microbe-free environment. In all these experiments, the mice developed severe pancreatic inflammation, a harbinger of type 1 diabetes — even when they carried the protective gene.
The findings were reported last week in the Proceedings of the National Academy of Sciences. Michael Silverman, MD, PhD, a fellow in Infectious Diseases at Boston Children’s Hospital, now at the Children’s Hospital of Philadelphia, was first author of the paper.
While humans and mice aren’t identical, the scientists say their findings point to a time window for proper development of the gut microbiome.
“Our results powerfully illustrate the notion that early antibiotic exposure can modulate disease risk, and that avoiding or at least minimizing antibiotic treatment in infants and pregnant women during critical periods of development may be a good idea,” says Mathis.
The researchers also believe their parallel finding in mice raised in sterile cages is consistent with the “hygiene hypothesis.” That hypothesis proposes that inadequate germ exposure during early childhood may increase later risk for allergic and autoimmune disease.
Poop transplants for type 1 diabetes?
This study shouldn’t be taken as a reason to withhold antibiotics from sick newborns or deliberately expose them to germs. But it does raise the interesting question of whether changing the microbiome could alter diabetes risk. In the study, genomic and proteomic analyses revealed that diabetes-prone mice with and without the protective gene hosted distinct intestinal microbiomes early in life.
In a final set of experiments, the team performed fecal transplants. These effectively gave diabetes-prone mice the same microbiome as their counterparts with the guardian gene. That was enough to dramatically reduce pancreatic cell inflammation and avert diabetes in these “at risk” mice.
Get more details on the research from Harvard Medical School.
Related Posts :
Unpacking the body’s interferon response to COVID-19
Interferons are potent natural antivirals, rallying other parts of the immune system to defend against viruses. Some clinical trials have ...
Why do some children get MIS-C after COVID-19? Some early clues
Several months into the COVID-19 pandemic, a small number of children began to develop a cluster of mysterious symptoms. These ...
Why do some people get severe COVID-19? The nose may know
The body’s first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A ...
A coming wave of diabetes? The link with COVID-19
Researchers are observing a new long-term health concern in patients hospitalized with COVID-19 — an increase in new-onset hyperglycemia lasting months ...